Volume 20, Issue 3 (َAutumn 2023)                   Sci J Iran Blood Transfus Organ 2023, 20(3): 236-254 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Javadzadeh Shahshahani H, Akhavan Tafti F, Amini Kafi‐abad S. An overview of three methods used to prepare the platelet components from whole blood and apheresis method. Sci J Iran Blood Transfus Organ 2023; 20 (3) :236-254
URL: http://bloodjournal.ir/article-1-1494-en.html
An overview of three methods used to prepare the platelet components from whole blood and apheresis method
H. Javadzadeh Shahshahani , F. Akhavan Tafti , S. Amini Kafi‐abad *
Keywords: Key words: Platelets, Platelet-Rich Plasma, Plateletpheresis
Full-Text [PDF 938 kb]   (976 Downloads)     |   Abstract (HTML)  (1456 Views)
Full-Text:   (2457 Views)
References:
  1. Javadzadeh Shahshahani H, Taghvaee N, Akhavan Tafti F. Frequency of blood components wastage and associated factors in Yazd healthcare centers. Iranian Journal of Blood and Cancer 2016; 8(4): 112-6.
  2. van der Meer PF, Reesink HW, de Korte D, Loos JA, Klei TR. The history of buffy coat platelet concentrates: The Dutch story. Vox Sang 2022; 17(7): 913-9.
  3. Vassallo RR, Murphy S. A critical comparison of platelet preparation methods. Curr Opin Hematol 2006; 13(5): 323-30.
  4. Murphy S, Gardner FH. Platelet preservation: effect of storage temperature on maintenance of platelet viability -deleterious effect of refrigerated storage.New England New England Journal of Medicine 1969; 280(20): 1094-8.
  5. Mehrizi TZ, Amini Kafiabad S, Eshghi P. Effects and treatment applications of polymeric nanoparticles on improving platelets' storage time: a review of the literature from 2010 to 2020. Blood Res 2021; 56(4): 215-28.
  6. Council of Europe. EDQM Guide to the Preparation, Use and Quality Assurance of Blood Components. Chapter 5.  19th  ed. Strasbourg:  Council    of    Europe Publishing; 2017. p. 252, 328-38.
  7. Rebulla P. In vitro and in vivo properties of various types of platelets. Vox Sang 1998; 74(S2): 217-22.
  8. Beshkar  P,  Pourfathollah  AA,  Shaiegan M, Akhound MR. Platelet activation and IL-8 production in platelet concentrates prepared by buffy coat and PRP method. Sci J Iran Blood Transfus Organ 2007; 4(1): 41-50. [Article in Farsi]
  9. Fijnheer R, Pietersz R, De Korte D, Gouwerok C, Dekker W, Reesink H, et al. Platelet activation during preparation of platelet concentrates: a comparison of the platelet-rich plasma and the buffy coat methods. Transfusion 1990; 30(7): 634-8.
  10. Chegini A, Mirrezaie SM, Poorreza M, Rezaie AR, Anbardan AJ. Assessment of plateletphersis donation in Tehran Blood Center. Sci J Iran Blood Transfus Organ 2013; 10(2): 140-6. [Article in Farsi]
  11. Acker J, Razatos A. Technical Manual. 19th ed. Bethesda, MD: AABB; 2017. p. 125-47 .
  12. Zolfaghari Anaraki S. The comprehensive atlas of blood transfusion. Medicine. 1st ed. Tehran: Teimurzadeh Publication; 2011. p. 85-109. [Persian]
  13. Fani P, Chegini A, Shaiegan M, Samiee S, Hajati E. Evaluation of post-donation blood cell changes in donors undergoing plateletpheresis by Haemonetics MCS+. Sci J Iran Blood Transfus Organ 2021; 18(3): 171-9. [Article in Farsi]
  14. Högman CF, Berséus O, Eriksson L, Gulliksson H. Buffy-coat-derived platelet concentrates: Swedish experience. Transfus Sci 1997; 18(1): 3-13.
  15. Levin E, Culibrk B, Gyöngyössy-Issa MI, Weiss S, Scammell K, LeFresne W, et al. Implementation of buffy coat platelet component production: comparison to platelet-rich plasma platelet production. Transfusion 2008; 48(11): 2331-7.
  16. Gammon RR, Devine D, Katz LM, Quinley E, Wu Y, Rowe K, et al. Buffy coat platelets coming to America: Are we ready? Transfusion 2021; 61(2): 627-33.
  17. Singh RP,  Marwaha  N,  Malhotra P,   Dash S. Quality assessment of platelet concentrates prepared by platelet rich plasma-platelet concentrate, buffy coat poor-platelet concentrate (BC-PC) and apheresis-PC methods. Asian J Transfus Sci 2009; 3(2): 86-94.
  18. Prins H, BRUIJN J, Henrichs H, Loos J. Prevention of microaggregate formation by removal of buffy-coats. Vox Sang 1980; 39(1): 48-51.
  19. Pietersz R, Loos J, Reesink H. Platelet concentrates stored in plasma for 72 hours at 22° C prepared from buffycoats of citrate-phosphate-dextrose blood collected in a quadruple-bag saline-adenine-glucose-mannitol system. Vox Sang 1985; 49(2): 81-5.
  20. Pietersz R, Reesink H, Dekker W, Fijen F. Preparation of Leukocyte-Poor Platelet Concentrates from Buffy Coats: Special Inserts for Centrifuge Cups. Vox Sang 1987; 53(4): 203-7.
  21. Pietersz R, De Korte D, Reesink H, Van den Ende A, Dekker W, Roos D. Preparation of Leukocyte-Poor Platelet Concentrates from Buffy Coats: III. Effect of Leukocyte Contamination on Storage Conditions. Vox Sang 1988; 55(1): 14-20.
  22. Pietersz R, Dekker W, Reesink H. Comparison of a conventional quadruple-bag system with a ‘top-and-bottom’system for blood processing. Vox Sang 1990; 59(4): 205-8.
  23. Van der Meer P, Pietersz R, Hinloopen B, Dekker W, Reesink H. Automated separation of whole blood in top and bottom bags into components using the Compomat G4. Vox Sang 1999; 76(2): 90-9.
  24. van der Meer PF, de Korte D. Platelet additive solutions: a review of the latest developments and their clinical implications. Transfus Med Hemother 2018; 45(2): 98-102.
  25. Murphy S, Rebulla P, Bertolini F, Holme S, Moroff G, Snyder E, et al. In vitro assessment of the quality of stored platelet concentrates. Transfus Med Rev 1994; 8(1): 29-36.
  26. De Wildt-Eggen J, Schrijver JG, Bins M, Gulliksson H. Storage of platelets in additive solutions: effects of magnesium and/or potassium. Transfusion 2002; 42(1): 76-80.
  27. Klinger MH, Josch M, Klüter H. Platelets stored in a glucose-free additive solution or in autologous plasma–an ultrastructural and morphometric evaluation. Vox Sang 1996; 71(1): 13-20.
  28. ang S, Wang T, Fan Y, Huang S, Yi Z, Li R, Zhao S. A comparison study of the blood component quality of whole blood held overnight at 4° c or room temperature. J Blood Transfu 2013; 2013: 523539.
  29. Slichter SJ, Corson J, Jones MK, Christoffel T, Pellham E, Bolgiano D. Platelet concentrates prepared after a 20-to 24-hour hold of the whole blood at 22° C. Transfusion 2012; 52(9): 2043-8.
  30. O'Neill E, Rowley J, Hansson-Wicher M, McCarter S, Ragno G, Valeri C. Effect of 24-hour whole-blood storageon plasma clotting factors. Transfusion 1999; 39(5): 488-91.
  31. Lu FQ, Kang W, Peng Y, Wang WM. Characterization of blood components separated from donated whole blood after an overnight holding at room temperature with the buffy coat method. Transfusion 2011; 51(10): 2199-207.
  32. Philip J, Samantha K, Chatterjee T, Biswas AK, Mallhi R. Evaluation of random donor platelets produced from buffy coat stored for 24 h at ambient temperature: should this be implemented in India? Indian J Hematol Blood Transfus 2015; 31(2): 264-8.
  33. Dijkstra-Tiekstra M, Van der Schoot C, Pietersz R, Reesink H. White blood cell fragments in platelet concentrates prepared by the platelet-rich plasma or buffy-coat methods. Vox Sang 2005; 88(4): 275-7.
  34. Dijkstra-Tiekstra MJ, Van der Meer PF, Cardigan R, Devine D, Prowse C, Sandgren P, de Wildt-Eggen J, Biomedical Excellence for Safer Transfusion Collaborative. Platelet concentrates from fresh or overnight-stored blood, an international study. Transfusion 2011; 51: 38S-44S.
  35. Feys H, Devloo R, Sabot B, Coene J, Compernolle V. Comparison of three commercially available buffy coat pooling sets for the preparation of platelet concentrates. Vox Sang 2018; 113(6): 555-61.
  36. Bontekoe I, van der Meer P, Mast G, de Korte D. Separation of centrifuged whole blood and pooled buffy coats using the new CompoMat G5: 3 years experience. Vox Sang 2014; 107(2): 140-7.
  37. Abedini M, Motamedi Z, Soleimany Ferizhandy A, Amini Kafi-Abad S. Evaluation and analysis of quality control results of Fresh Frozen Plasma units in Iranian blood transfusion centers during 1397-1398. Sci J Iran Blood Transfus Organ 2021; 18(2): 71-8. [Article in Farsi]
  38. Schiffer CA. Platelet transfusion: quality control. In: Smit Sibinga C.TH, Das PC, Taswell HF. Quality Assurance in Blood Banking and Its Clinical Impact. UK: Springer; 1984. p. 177-85.
  39. Ghezelbash B, Amini Kafiabad S, Hojjati MT, Hamidpoor M, Vaeli S, Tabtabae MR, et al. In vitro assessment of platelet lesions during 5-day storage in Iranian Blood Transfusion Organization (IBTO) centers. Arch Iran Med 2015; 18(2): 114-6.
  40. Heddle NM, Arnold DM, Boye D, Webert KE, Resz I, Dumont LJ. Comparing the efficacy and safety of apheresis and whole blood–derived platelet transfusions: a systematic review. Transfusion 2008; 48(7): 1447-58.
  41. Murphy S. Platelets from pooled buffy coats: an update. Transfusion 2005; 45(4): 634-9.
  42. Washitani Y, Irita Y, Yamamoto K, Shiraki H, Kiyokawa H, Maeda Y, et al. Prevention of acquired defects in platelet function during blood processing. Transfusion 1988; 28(6): 571-5.
  43. Ojha S, Tirlotkar A, Gupta AM, Sumathi S, Chavan P, Poojary M. Comparative analysis of platelet concentrates prepared after two hours and overnight storage of buffy coat at room temperature. Transfus Apher Sci 2021; 60(1): 103014.
  44. Vasconcelos E, Figueiredo A, Seghatchian J. Quality of platelet concentrates derived by platelet rich plasma, buffy coat and apheresis. Transfus Apher Sci 2003; 29(1): 13-6.
  45. Devine DV,  Serrano  K. Preparation of blood products for transfusion: is there a best method? Biologicals 2012; 40(3): 187-90.
  46. Eernisse   J,    Brand    A.  Prevention   of     platelet refractoriness due to HLA antibodies by administration of leukocyte-poor blood components. Exp Hematol 1981; 9(1): 77-83.
  47. Dijkstra-Tiekstra M, Pietersz R, Reesink H, Van Der Schoot C. Influence of cell-free DNA in plasma on real-time polymerase chain reaction for determination of residual leucocytes in platelet concentrates. Vox Sang 2004; 86(2): 130-5.
  48. Bikker A, Bouman E, Sebastian S, Korporaal SJ, Urbanus RT, Fijnheer R, et al. Functional recovery of stored platelets after transfusion. Transfusion 2016; 56(5): 1030-7.
  49. Murphy S. Collaborative platelets from pooled buffy coats: an update. Tansfusion 2005; 45(4): 634-9.
  50. Bertolini F, Rebulla P, Riccardi D, Cortellaro M, Ranzi M, Sirchia G. Evaluation of platelet concentrates prepared from buffy coats and stored in a glucose-free crystalloid medium. Transfusion 1989; 29(7): 605-9.
  51. Schrezenmeier H, Seifried E. Buffy-coat-derived pooled platelet concentrates and apheresis platelet concentrates: which product type should be preferred? Vox Sang 2010; 99(1): 1-15.
  52. Javadzadeh Shahshahani H, Hatami H, Meraat N, Savabieh S. Epidemiology of blood component recipients in hospitals of Yazd, Iran. Transfus Med 2015; 25(1): 2-7. 
  53. Taghvaie N, Javadzadeh Shahshahani H, Akhavanetafti F, Shishehbor A. Investigating the age changes of Yazd blood donors in 2011 to 2018. Sci J Iran Blood Transfus Organ 2021; 18(1): 9-17.
  54. Van der Meer P. PAS or plasma for storage of platelets? A concise review. Transfus Med 2016; 26(5): 339-42.









 
Type of Study: Review Article | Subject: Blood Transfusion
Published: 2023/09/1
Add your comments about this article : Your username or Email:
CAPTCHA
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2025 CC BY-NC 4.0 | Scientific Journal of Iran Blood Transfus Organ

Designed & Developed by : Yektaweb